Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B
We report the case of a 19-year-old male with possible cerebral mucormycosis following chemotherapy. We detected a Lichtheimia DNA load of 2.0 × 104 copies/ml in cerebrospinal fluid (CSF), although a CSF culture showed no growth. After treatment with intravenous liposomal amphotericin B, the Lichthe...
Main Authors: | Tomonari Shigemura, Yozo Nakazawa, Kazuyuki Matsuda, Mitsuo Motobayashi, Shoji Saito, Kenichi Koike |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-12-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971214016750 |
Similar Items
-
Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01) -
Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India
by: Jagdish Chander, et al.
Published: (2018-04-01) -
Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
by: Marjorie Cornu, et al.
Published: (2018-12-01) -
The Role of Retrobulbar Injection of Amphotericin B in the Management of Orbital Mucormycosis in a Tertiary Care Centre—Prospective Analytical Study
by: A Yogeswari, et al.
Published: (2023-01-01) -
Rhino–Orbito–Cerebral Mucormycosis Resistant to Amphotericin B: Two Diabetic Cases
by: Esma Eren, et al.
Published: (2019-09-01)